Publications - IR Sant Pau

Search

01/07/2021 Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry

Stephens, C, Robles-Diaz, M, Medina-Caliz, I, Garcia-Cortes, M, Ortega-Alonso, A, Sanabria-Cabrera, J, Gonzalez-Jimenez, A, Alvarez-Alvarez, I, Slim, M, Jimenez-Perez, M, Gonzalez-Grande, R, Fernandez, MC, Casado, M, Soriano, G, Roman, E, Hallal, H, Romero-Gomez, M, Castiella, A, Conde, I, Prieto, M, Moreno-Planas, JM, Giraldez, A, Moreno-Sanfiel, JM, Kaplowitz, N, Lucena, MI, Andrade, RJ, Participating Clinical Ctr. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry. JOURNAL OF HEPATOLOGY. 2021; 75(1)DOI:10.1016/j.jhep.2021.01.029. PMID:33539847. IF:30.083(Q1/1D).

02/11/2022 Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study

Chaparro, M, Baston-Rey, I, Fernandez-Salgado, E, Garcia, JG, Ramos, L, Palomares, MTDL, Arguelles-Arias, F, Flores, EI, Cabello, M, Iturria, SR, Ortiz, AN, Charro, M, Ginard, D, Sadornil, CD, Ochoa, OM, Busquets, D, Iyo, E, Casbas, AG, de la Piscina, PR, Bosca-Watts, MM, Arroyo, M, Garcia, MJ, Hinojosa, E, Gordillo, J, Montiel, PM, Jimenez, BV, Ivorra, CQ, Moron, JMV, Huguet, JM, Gonzalez-Lama, Y, Santos, AIM, Amo, VM, Martin-Arranz, MD, Bermejo, F, Cadilla, JM, de Celix, CR, Salazar, PF, San Roman, AL, Jimenez, N, Lopez, SG, Figuerola, A, Jimenez, I, Cerezo, FJM, Taxonera, C, Varela, P, de Francisco, R, Monfort, D, Arriero, GM, Camba, AH, Garcia-Alonso, FJ, Van Domselaar, M, Villarroya, RP, Nunez, A, Moranta, FR, Marin-Jimenez, I, Alonso, VR, Rodriguez, MDM, Camo-Monterde, P, Tercero, IG, Llavat, MN, Garcia, LA, Cruz, DH, Sulleiro, S, Novella, C, Vispo, E, Barreiro-de Acosta, M, Gisbert, JP. Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study. INFLAMMATORY BOWEL DISEASES. 2022; 28(11)DOI:10.1093/ibd/izab357. PMID:35166347. IF:4.900(Q2/3D).

01/10/2022 Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease

Bassegoda O., Olivas P., Turco L., Mandorfer M., Serra-Burriel M., Tellez L., Kwanten W., Laroyenne A., Farcau O., Alvarado E., Moga L., Vuille-Lessard E., Fortea J.I., Ibañez L., Tosetti G., Vanwolleghem T., Larrue H., Burgos-Santamaría D., Stefanescu H., Paternostro R., Cippitelli A., Lens S., Augustin S., Llop E., Laleman W., Trebicka J., Chang J., Masnou H., Zipprich A., Miceli F., Semmler G., Forns X., Primignani M., Bañares R., Puente A., Berzigotti A., Rautou P.E., Villanueva C., Ginès P., Garcia-Pagan J.C., Procopet B., Bureau C., Albillos A., Francque S., Reiberger T., Schepis F., Graupera I., Hernandez-Gea V.. Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease. Clinical Gastroenterology and Hepatology. 2022; 20(10)DOI:10.1016/j.cgh.2021.10.023. PMID:34688952. IF:12.600(Q1/1D).

04/08/2022 Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCU

Barreiro-de Acosta, M, Riestra, S, Calafat, M, Soto, MP, Calvo, M, Rodriguez, ES, Caballol, B, Vela, M, Rivero, M, Munoz, F, de Castro, L, Calvet, X, Garcia-Alonso, FJ, Fornals, AU, Ferreiro-Iglesias, R, Gonzalez-Munoza, C, Chaparro, M, Bujanda, L, Sicilia, B, Alfambra, E, Rodriguez, A, Fernandez, RP, Rodriguez, C, Almela, P, Arguelles, F, Busquets, D, Tamarit-Sebastian, S, Castro, CR, Jimenez, L, Marin-Jimenez, I, Alcaide, N, Fernandez-Salgado, E, Iglesias, A, Ponferrada, A, Pajares, R, Roncero, O, Morales-Alvarado, VJ, Ispizua-Madariaga, N, Sainz, E, Merino, O, Marquez-Mosquera, L, Garcia-Sepulcre, M, Elorza, A, Estrecha, S, Suris, G, Van Domselaar, M, Brotons, A, de Francisco, R, Canete, F, Iglesias, E, Vera, MI, Mesonero, F, Lorente, R, Zabana, Y, Cabriada, JL, Domenech, E, Rodriguez-Lago, I. Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCU. Journal of Crohns & Colitis. 2022; 16(7)DOI:10.1093/ecco-jcc/jjac016. PMID:35104314. IF:8.000(Q1/2D).

01/07/2022 Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases

Baiges A., Cerda E., Amicone C., Téllez L., Alvarado-Tapias E., Puente A., Fortea J.I., Llop E., Rocha F., Orts L., Ros-Fargas O., Vizcarra P., Zekrini K., Lounes O.A., Touati G., Jiménez-Esquivel N., Serrano M.J., Falgà A., Magaz M., Olivas P., Betancourt F., Perez-Campuzano V., Turon F., Payancé A., Goria O., Rautou P.-E., Hernández-Gea V., Villanueva C., Albillos A., Plessier A., García-Pagán J.-C.. Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases. Clinical Gastroenterology and Hepatology. 2022; 20(7)DOI:10.1016/j.cgh.2021.12.032. PMID:34968728. IF:12.600(Q1/1D).

01/05/2022 Location, morphology and invasiveness of lateral spreading tumors in the colorectum differ between two large cohorts from an eastern and western country

Guarner-Argente C., Ikematsu H., Osera S., Fraile M., Ibañez B., Marra-López C., Jerusalén-Gargallo C., Alonso Aguirre P.A., Martinez-Ares D., Soto S., Ramos Zabala F., Alvarez-Gonzalez M.A., Rodriguez Sánchez J., Múgica F., Nogales Rincon O., Herreros de Tejada A., Redondo-Cerezo E., Martínez-Cara J., López-Rosés L., Rodriguez-Tellez M., Garcia-Bosch O., de la Peña J., Pellisé M., Rivero-Sanchez L., Saperas E., Pérez-Roldán F., Lopez Viedma B., González-Santiago J.M., Álvarez Delgado A., Cobian C., Pardeiro R., Valdivielso Cortázar E., Colan-Hernandez J., Gordillo J., Kaneko K., Albéniz E.. Location, morphology and invasiveness of lateral spreading tumors in the colorectum differ between two large cohorts from an eastern and western country. Gastroenterologia y Hepatologia. 2022; 45(6)DOI:10.1016/j.gastrohep.2021.07.005. PMID:34400187. IF:(Q/D).

01/05/2022 Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry

Hernández-Camba A., Arranz L., Vera I., Carpio D., Calafat M., Lucendo A.J., Taxonera C., Marín S., Garcia M.J., Marín G.S., Rodríguez E.S., Carbajo A.Y., De Castro M.L., Iborra M., Martin-Cardona A., Rodríguez-Lago I., Busquets D., Bertoletti F., Ausín M.S., Tardillo C., Malaves J.H., Bujanda L., Castaño A., Domènech E., Ramos L., Merino O.. Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry. DIGESTIVE AND LIVER DISEASE. 2022; 54(5)DOI:10.1016/j.dld.2021.10.002. PMID:34862115. IF:4.500(Q2/4D).

01/05/2022 Effect of rifaximin on infections, acute-on-chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA-AH)

Jimenez, C, Ventura-Cots, M, Sala, M, Calafat, M, Garcia-Retortillo, M, Cirera, I, Canete, N, Soriano, G, Poca, M, Simon-Talero, M, Altamirano, J, Lucey, M, Garcia-Tsao, G, Brown, RS, Schwabe, RF, Verna, EC, Schnabl, B, Bosques-Padilla, F, Mathurin, P, Caballeria, J, Louvet, A, Shawcross, DL, Abraldes, JG, Genesca, J, Bataller, R, Vargas, V. Effect of rifaximin on infections, acute-on-chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA-AH). LIVER INTERNATIONAL. 2022; 42(5)DOI:10.1111/liv.15207. PMID:35220659. IF:6.700(Q1/3D).

01/04/2022 Chronic pancreatitis for the clinician. Part 2: Treatment and follow-up. Interdisciplinary Position Paper of the Societat Catalana de Digestologia and the Societat Catalana de Pancrees

Molero X., Ayuso J.R., Balsells J., Boadas J., Busquets J., Casteràs A., Concepción M., Cuatrecasas M., Fernàndez Esparrach G., Fort E., Garcia Borobia F., Ginès À., Ilzarbe L., Loras C., Masachs M., Merino X., Olsina J.J., Puig-Diví V., Salord S., Serrano T., Vaquero E.C.. Chronic pancreatitis for the clinician. Part 2: Treatment and follow-up. Interdisciplinary Position Paper of the Societat Catalana de Digestologia and the Societat Catalana de Pancrees. Gastroenterologia y Hepatologia. 2022; 45(4)DOI:10.1016/j.gastrohep.2021.05.016. PMID:34171422. IF:1.900(Q4/10D).

01/03/2022 Chronic pancreatitis for the clinician. Part 1: Etiology and diagnosis. Interdisciplinary position paper of the Societat Catalana de Digestologia and the Societat Catalana de Pancrees

Molero, X, Ayuso, JR, Balsells, J, Boadas, J, Busquets, J, Casteras, A, Concepcion, M, Cuatrecasas, M, Esparrach, GF, Fort, E, Borobia, FG, Gines, A, Ilzarbe, L, Loras, C, Masachs, M, Merino, X, Olsina, JJ, Puig-Divi, V, Salord, S, Serrano, T, Vaquero, EC. Chronic pancreatitis for the clinician. Part 1: Etiology and diagnosis. Interdisciplinary position paper of the Societat Catalana de Digestologia and the Societat Catalana de Pancrees. Gastroenterologia y Hepatologia. 2022; 45(3)DOI:10.1016/j.gastrohep.2021.05.017. PMID:34157366. IF:1.900(Q4/10D).

01/03/2022 Endoscopy-Related Bleeding and Thromboembolic Events in Patients on Direct Oral Anticoagulants or Vitamin K Antagonists

de Santiago, ER, Aldehuelo, RS, Pons, FR, Escaja, CR, Fernandez-Esparrach, G, Canete-Ruiz, A, Aracil, CF, Perez-Corte, D, Leon, RR, Marcos-Prieto, HM, Delgado-Guillena, PG, Garcia-Rodriguez, A, Guarner-Argente, C, Muriel, A, de la Fuente-Briongos, E, de Paredes, AGG, Parejo-Carbonell, S, Tellez, L, Senosiain-Lalastra, C, Burgos-Santamaria, D, Aicart-Ramos, M, Munoz, BM, Penas-Garcia, B, Pagano, G, Urquiza, GC, Ferreruela, MU, de Jorge-Turrion, MA, Barreiro-Alonso, E, Fraile-Lopez, M, Gomez-Outomuro, A, Altamirano, MI, Esteban, MN, Ruiz-Andreu, M, Arribas-Anta, J, de Frutos, D, Herreros-de-Tejada, A, Arias-Rivera, ML, Roldan-Fernandez, M, Martin, AFM, Zamora, J, Vazquez-Sequeiros, E, Albillos, A. Endoscopy-Related Bleeding and Thromboembolic Events in Patients on Direct Oral Anticoagulants or Vitamin K Antagonists. Clinical Gastroenterology and Hepatology. 2022; 20(3)DOI:10.1016/j.cgh.2020.11.037. PMID:33279783. IF:12.600(Q1/1D).

01/02/2022 Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

Gutierrez, A, Zapater, P, Ricart, E, Gonzalez-Vivo, M, Gordillo, J, Olivares, D, Vera, I, Manosa, M, Gisbert, JP, Aguas, M, Sanchez-Rodriguez, E, Bosca-Watts, M, Laredo, V, Camps, B, Marin-Jimenez, I, Zabana, Y, Martin-Arranz, MD, Munoz, R, Navarro, M, Sierra, E, Madero, L, Vela, M, Perez-Calle, JL, Sainz, E, Calvet, X, Arias, L, Morales, V, Bermejo, F, Fernandez-Salazar, L, Van Domselaar, M, De Castro, L, Rodriguez, C, Munoz-Villafranca, C, Lorente, R, Rivero, M, Iglesias, E, Herreros, B, Busquets, D, Riera, J, Martinez-Montiel, MP, Roldon, M, Roncero, O, Hinojosa, E, Sierra, M, Barrio, J, De Francisco, R, Huguet, J, Merino, O, Carpio, D, Ginard, D, Munoz, F, Marta, P, Almela, P, Argueelles-Arias, F, Alcain, G, Luis, B, Mancenido, N, Lucendo, AJ, Varela, P, Rodriguez-Lago, I, Ramos, L, Laura, S, Sese, E, Acosta, MBD, Domenech, E, Frances, R. Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients. Frontiers in Medicine. 2022; 9DOI:10.3389/fmed.2022.823900. PMID:35178413. IF:3.900(Q2/4D).

01/01/2022 Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNF alpha used for the treatment of IBD: Results from the VERNE study

Batista, G, Marin-Jimenez, I, Fores, A, Garcia-Planella, E, Arguelles-Arias, F, Tagarro, I, Fernandez-Nistal, A, Montoto, C, Aparicio, J, Aguas, M, Santos-Fernandez, J, Bosca-Watts, MM, Ferreiro-Iglesias, R, Merino, O, Aldeguer, X, Corttes, X, Sicilia, B, Mesonero, F, Barreiro-de Acosta, M. Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNF alpha used for the treatment of IBD: Results from the VERNE study. DIGESTIVE AND LIVER DISEASE. 2022; 54(1)DOI:10.1016/j.dld.2021.06.005. PMID:34244110. IF:4.500(Q2/4D).

01/01/2022 Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

Zabana, Y, Marin-Jimenez, I, Rodriguez-Lago, I, Vera, I, Martin-Arranz, MD, Guerra, I, Gisbert, JP, Mesonero, F, Benitez, O, Taxonera, C, Ponferrada-Diaz, A, Piqueras, M, Lucendo, AJ, Caballol, B, Manosa, M, Martinez-Montiel, P, Bosca-Watts, M, Gordillo, J, Bujanda, L, Mancenido, N, Martinez-Perez, T, Lopez, A, Rodriguez-Gutierrez, C, Garcia-Lopez, S, Vega, P, Rivero, M, Melcarne, L, Calvo, M, Iborra, M, de-Acosta, MB, Sicilia, B, Barrio, J, Perez, JL, Busquets, D, Perez-Martinez, I, Navarro-Llavat, M, Hernandez, V, Argueelles-Arias, F, Esteso, FR, Meijide, S, Ramos, L, Gomollon, F, Munoz, F, Suris, G, de Zarate, JO, Huguet, JM, Llao, J, Garcia-Sepulcre, MF, Sierra, M, Dura, M, Estrecha, S, Coronel, AF, Hinojosa, E, Olivan, L, Iglesias, E, Gutierrez, A, Varela, P, Rull, N, Gilabert, P, Hernandez-Camba, A, Brotons, A, Ginard, D, Sese, E, Carpio, D, Aceituno, M, Cabriada, JL, Gonzalez-Lama, Y, Jimenez, L, Chaparro, M, Roman, ALS, Alba, C, Plaza-Santos, R, Mena, R, Tamarit-Sebastian, S, Ricart, E, Calafat, M, Olivares, S, Navarro, P, Bertoletti, F, Alonso-Galan, H, Pajares, R, Olcina, P, Manzano, P, Domenech, E, Esteve, M. Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry. Journal of Clinical Medicine. 2022; 11(2)DOI:10.3390/jcm11020421. PMID:35054116. IF:3.900(Q2/4D).

01/12/2021 Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis

de Paredes, AGG, Villanueva, C, Blanco, C, Genesca, J, Manicardi, N, Garcia-Pagan, JC, Calleja, JL, Aracil, C, Morillas, RM, Poca, M, Penas, B, Augustin, S, Abraldes, JG, Alvarado, E, Royo, F, Garcia-Bermejo, ML, Falcon-Perez, JM, Banares, R, Bosch, J, Gracia-Sancho, J, Albillos, A. Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis. Jhep Reports. 2021; 3(6)DOI:10.1016/j.jhepr.2021.100368. PMID:34712934. IF:9.917(Q1/2D).

01/11/2021 Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry

Chaparro, M, Garre, A, Iborra, M, Sierra-Ausin, M, Barreiro-de Acosta, M, Fernandez-Clotet, A, de Castro, L, Bosca-Watts, M, Casanova, MJ, Lopez-Garcia, A, Lorente, R, Rodriguez, C, Carbajo, AY, Arroyo, MT, Gutierrez, A, Hinojosa, J, Martinez-Perez, T, Villoria, A, Bermejo, F, Busquets, D, Camps, B, Canete, F, Mancenido, N, Monfort, D, Navarro-Llavat, M, Perez-Calle, JL, Ramos, L, Rivero, M, Angueira, T, Monterde, PC, Carpio, D, Garcia-de-la-Filia, I, Gonzalez-Munoza, C, Hernandez, L, Huguet, JM, Morales, VJ, Sicilia, B, Vega, P, Vera, I, Zabana, Y, Nos, P, Alvarez, PS, Calvino-Suarez, C, Ricart, E, Hernandez, V, Minguez, M, Marquez, L, Cruz, DH, Iturria, SR, Barrio, J, Gargallo-Puyuelo, C, Frances, R, Hinojosa, E, del Moral, M, Calvet, X, Algaba, A, Aldeguer, X, Guardiola, J, Manosa, M, Pajares, R, Piqueras, M, Garcia-Bosch, O, Serrano, PL, Castro, B, Lucendo, AJ, Montoro, M, Ortiz, EC, Mesonero, F, Garcia-Planella, E, Fuentes, DA, Bort, I, Delgado-Guillena, P, Arias, L, Iglesias, A, Calvo, M, Esteve, M, Domenech, E, Gisbert, JP. Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry. Journal of Crohns & Colitis. 2021; 15(11)DOI:10.1093/ecco-jcc/jjab070. PMID:33860795. IF:10.020(Q1/2D).

01/11/2021 Effects of Albumin on Survival after a Hepatic Encephalopathy Episode: Randomized Double-Blind Trial and Meta-Analysis

Ventura-Cots, M, Simon-Talero, M, Poca, M, Ariza, X, Masnou, H, Sanchez, J, Llop, E, Canete, N, Martin-Llahi, M, Amador, A, Martinez, J, Clemente-Sanchez, A, Puente, A, Torrens, M, Alvarado-Tapias, E, Napoleone, L, Miquel-Planas, M, Ardevol, A, Rodrigo, MC, Calleja, JL, Sole, C, Soriano, G, Genesca, J. Effects of Albumin on Survival after a Hepatic Encephalopathy Episode: Randomized Double-Blind Trial and Meta-Analysis. Journal of Clinical Medicine. 2021; 10(21)DOI:10.3390/jcm10214885. PMID:34768404. IF:4.964(Q2/4D).

01/11/2021 Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study

Reig, A, Alvarez-Navascues, C, Vergara, M, Gomez-Dominguez, E, Gallego-Moya, A, Perez-Medrano, IM, Fabrega, E, Hernandez-Guerra, M, Berenguer, M, Estevez, P, Arencibia, A, Morillas, RM, Horta, D, Albillos, A, Casado, M, De la Cruz, G, Fernandez-Bonilla, E, Molina, E, Hijona, L, Diago, M, Fernandez-Rodriguez, CM, Gonzalez-Santiago, JM, Sala, M, Gomez-Camarero, J, Romero-Gomez, M, Suarez, F, Vargas, V, Ferre-Aracil, C, Andrade, RJ, Chahri, N, Pares, A. Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2021; 116(11)DOI:10.14309/ajg.0000000000001343. PMID:34158466. IF:12.045(Q1/1D).

07/03/2023 Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding

Rudler, M, Hernandez-Gea, V, Procopet, BD, Giraldez, A, Amitrano, L, Villanueva, C, Ibanez, L, Silva, G, Genesca, J, Bureau, C, Trebicka, J, Banares, R, Krag, A, Llop, E, Laleman, W, Palazon, JM, Castellote, J, Rodrigues, S, Gluud, LL, Ferreira, CN, Canete, N, Rodriguez, M, Ferlitsch, A, Mundi, JL, Gronbaek, H, Hernandez-Guerra, M, Sassatelli, R, Dell'era, A, Senzolo, M, Abraldes, JG, Romero-Gomez, M, Zipprich, A, Casas, M, Masnou, H, Larrue, H, Primignani, M, Nevens, F, Calleja, JL, Schwarzer, R, Jansen, C, Robic, MA, Conejo, I, Gonzalez, JM, Catalina, MV, Albillos, A, Alvarado, E, Guardascione, MA, Mallet, M, Tripon, S, Casanovas, G, Bosch, J, Garcia-Pagan, JC, Thabut, D. Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding. GUT. 2023; 72(4)DOI:10.1136/gutjnl-2022-326975. PMID:36328772. IF:23.100(Q1/1D).

27/01/2023 Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry

Casas-Deza D., Lamuela-Calvo L.J., Gomollón F., Arbonés-Mainar J.M., Caballol B., Gisbert J.P., Rivero M., Sánchez-Rodríguez E., García L.A., Casbas A.G., Merino O., Márquez L., Laredo V., Martín-Arranz M.D., Serrano P.L., Menéndez S.R., González-Muñoza C., Parga, LD, Moya M.C., Fuentes-Valenzuela E., Esteve M., Iborra M., Gil M.D., Barreiro-De Acosta, M, Lorente-Poyatos R.H., Mancenido, N, Calafat M., Rodríguez-Lago I., Capo J.G., Payeras M.A., Alvarado, VJM, Tardillo C., Bujanda L., Munoz-Nunez, JF, Nieto Y.B., Bermejo F., Almela P., Navarro-Llavat M., Montiel P.M., Gutiérrez C.R., Van Domselaar M., Sesé E., Pérez T.M., Ricart E., Chaparro M., García M.J., López-Sanromán A., Sicilia B., Orts B., López-García A., Martín-Arranz E., Pérez-Calle J.L., de Francisco R., García-Planella E., Domenech, E, García-López S.. Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry. Journal of Crohns & Colitis. 2023; 17(1)DOI:10.1093/ecco-jcc/jjac108. PMID:35913456. IF:8.300(Q1/1D).

01/10/2022 Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients

Gil-Gomez, A, Rojas, A, Garcia-Lozano, MR, Munoz-Hernandez, R, Gallego-Duran, R, Maya-Miles, D, Montero-Vallejo, R, Gato, S, Gallego, J, Frances, R, Soriano, G, Ampuero, J, Romero-Gomez, M. Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(19)DOI:10.3390/ijms231911840. PMID:36233142. IF:5.600(Q1/3D).

01/10/2022 Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (vol 10, 2885, 2021)

Chaparro, M, Garre, A, Ortiz, AN, Palomares, MTDL, Rodriguez, C, Riestra, S, Vela, M, Benitez, JM, Salgado, EF, Rodriguez, ES, Hernandez, V, Ferreiro-Iglesias, R, Diaz, AP, Barrio, J, Huguet, JM, Sicilia, B, Martin-Arranz, MD, Calvet, X, Ginard, D, Alonso-Abreu, I, Fernandez-Salazar, L, Trastoy, PV, Rivero, M, Vera-Mendoza, I, Vega, P, Navarro, P, Sierra, M, Cabriada, JL, Aguas, M, Vicente, R, Navarro-Llavat, M, Echarri, A, Gomollon, F, del Rio, EG, Pinero, C, Casanova, MJ, Spicakova, K, de Zarate, JO, Cortes, ET, Gutierrez, A, Alonso-Galan, H, Hernandez-Martinez, A, Marrero, JM, Poyatos, RL, Calafat, M, Romero, LM, Robledo, P, Bosch, O, Jimenez, N, Comas, ME, Duque, JM, Coronel, AMF, Sampedro, MJ, Abizanda, ES, Martinez, BH, Pozzati, L, Rosaenz, HF, Suarez, BC, Serrano, PL, Lucendo, AJ, Vicente, MM, Bermejo, F, Palanca, JJR, Menacho, M, Carmona, A, Camargo, R, Alsina, ST, Maroto, N, de la Puerta, JN, Castro, E, Marin-Jimenez, I, Botella, B, Sapina, A, Cruz, N, Forcelledo, JLF, Bouhmidi, A, Castano-Milla, C, Opio, V, Nicolas, I, Kutz, M, Bechiarelli, AA, Gordillo, J, Ber, Y, Dominguez, YT, Duran, MTN, Mondejar, SR, Martinez-Cerezo, FJ, Kolle, L, Sabat, M, Ledezma, C, Iyo, E, Roncero, O, Irisarri, R, Lluis, L, Gomez, IB, Zapata, EM, Alcala, MJ, Pascual, CM, Montealegre, M, Mata, L, Monrobel, A, Camba, AH, Hernandez, L, Tejada, M, Mir, A, Galve, ML, Soler, M, Hervias, D, Gomez-Valero, JA, Acosta, MBD, Rodriguez-Artalejo, F, Garcia-Esquinas, E, Gisbert, JP. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (vol 10, 2885, 2021). Journal of Clinical Medicine. 2022; 11(19)DOI:10.3390/jcm11195816. PMID:36233844. IF:3.900(Q2/4D).

01/10/2022 Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis

Villanueva, C, Torres, F, Sarin, SK, Shah, HA, Tripathi, D, Brujats, A, Rodrigues, SG, Bhardwaj, A, Azam, Z, Hayes, PC, Jindal, A, Abid, S, Alvarado, E, Bosch, J, Carvedilol IPD MA Grp, Baveno Cooperation EASL Consortium. Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis. JOURNAL OF HEPATOLOGY. 2022; 77(4)DOI:10.1016/j.jhep.2022.05.021. PMID:35661713. IF:25.700(Q1/1D).

21/09/2022 Experimental and genetic evidence for the impact of CD5 and CD6 expression and variation in inflammatory bowel disease

Casado-Llombart, S, Velasco-de Andres, M, Catala, C, Leyton-Pereira, A, Gutierrez-Cozar, R, Suarez, B, Armiger, N, Carreras, E, Esteller, M, Ricart, E, Ordas, I, Gisbert, JP, Chaparro, M, Esteve, M, Marquez, L, Busquets, D, Iglesias, E, Garcia-Planella, E, Martin-Arranz, MD, Lohmann, J, Ayata, CK, Niess, JH, Engel, P, Panes, J, Salas, A, Domenech, E, Lozano, F. Experimental and genetic evidence for the impact of CD5 and CD6 expression and variation in inflammatory bowel disease. Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.966184. PMID:36211446. IF:7.300(Q1/3D).

01/08/2022 Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab

Chaparro, M, Baston-Rey, I, Salgado, EF, Garcia, JG, Ramos, L, Palomares, MTDL, Arguelles-Arias, F, Flores, EI, Cabello, M, Iturria, SR, Ortiz, AN, Charro, M, Ginard, D, Sadornil, CD, Ochoa, OM, Busquets, D, Iyo, E, Casbas, AG, de la Piscina, PR, Bosca-Watts, MM, Arroyo, M, Garcia, MJ, Hinojosa, E, Gordillo, J, Montiel, PM, Jimenez, BV, Ivorra, CQ, Moron, JMV, Huguet, JM, Gonzalez-Lama, Y, Santos, AIM, Amo, VM, Arranz, MDM, Bermejo, F, Cadilla, JM, de Celix, CR, Salazar, PF, San Roman, AL, Jimenez, N, Garcia-Lopez, S, Figuerola, A, Jimenez, I, Cerezo, FJM, Taxonera, C, Varela, P, de Francisco, R, Monfort, D, Arriero, GM, Hernandez-Camba, A, Alonso, FJG, Van Domselaar, M, Pajares-Villarroya, R, Nunez, A, Moranta, FR, Marin-Jimenez, I, Alonso, VR, Rodriguez, MDM, Camo-Monterde, P, Tercero, IG, Navarro-Llavat, M, Garcia, LA, Cruz, DH, Kloss, S, Passey, A, Novella, C, Vispo, E, Barreiro-de Acosta, M, Gisbert, JP. Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab. Journal of Clinical Medicine. 2022; 11(15)DOI:10.3390/jcm11154518. PMID:35956133. IF:3.900(Q2/4D).

01/07/2022 Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU

Riestra, S, Taxonera, C, Zabana, Y, Carpio, D, Chaparro, M, Barrio, J, Rivero, M, Lopez-Sanroman, A, Esteve, M, de Francisco, R, Bastida, G, Garcia-Lopez, S, Manosa, M, Martin-Arranz, MD, Perez-Calle, JL, Guardiola, J, Munoz, F, Arranz, L, Cabriada, JL, Garcia-Sepulcre, MF, Navarro, M, Montoro-Huguet, MA, Ricart, E, Bermejo, F, Calvet, X, Piqueras, M, Garcia-Planella, E, Marquez, L, Minguez, M, Van Domselar, M, Bujanda, L, Aldeguer, X, Sicilia, B, Iglesias, E, Alcain, G, Perez-Martinez, I, Rolle, V, Castano-Garcia, A, Gisbert, JP, Domenech, E. Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU. Journal of Clinical Medicine. 2022; 11(13)DOI:10.3390/jcm11133915. PMID:35807201. IF:3.900(Q2/4D).

01/12/2024 Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)

Alvarado-Tapias, E, Maya-Miles, D, Albillos, A, Aller, R, Ampuero, J, Andrade, RJ, Arechederra, M, Aspichueta, P, Banales, JM, Blas-Garcia, A, Caparros, E, Delgado, TC, Carrillo-Vico, A, Claria, J, Cubero, FJ, Diaz-Ruiz, A, Fernandez-Barrena, MG, Fernandez-Iglesias, A, Fernandez-Veledo, S, Frances, R, Gallego-Duran, R, Gracia-Sancho, J, Irimia, M, Lens, S, Martinez-Chantar, ML, Minguez, B, Munoz-Hernandez, R, Nogueiras, R, Ramos-Molina, B, Riveiro-Barciela, M, Rodriguez-Peralvarez, ML, Romero-Gomez, M, Sabio, G, Sancho-Bru, P, Ventura-Cots, M, Vidal, S, Gahete, MD. Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH). Gastroenterologia y Hepatologia. 2024; 47(10)DOI:10.1016/j.gastrohep.2024.502207. PMID:38723772. IF:1.900(Q3/7D).

01/12/2024 Perception of the impact of intravenous biological treatment on the work and professional environment in patients with inflammatory bowel disease

González-Muñoza, C, Gely, C, Gordillo, J, Calafat, M, Bertoletti, F, Cañete, F, Mañosa, M, López-Faba, A, Torres, P, Domènech, E, Garcia-Planella, E. Perception of the impact of intravenous biological treatment on the work and professional environment in patients with inflammatory bowel disease. Gastroenterologia y Hepatologia. 2024; 47(10)DOI:10.1016/j.gastrohep.2024.502193. PMID:38723767. IF:1.900(Q3/7D).

01/11/2024 Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU

Casanova, MJ, Caballol, B, García, MJ, Mesonero, F, de Célix, CR, Suárez-Alvarez, P, Ferreiro-Iglesias, R, Martín-Rodríguez, MDM, de Francisco, R, Varela-Trastoy, P, Bastida, G, Carrillo-Palau, M, Núñez-Ortiz, A, Ramírez-de la Piscina, P, Ceballos, D, Hervías-Cruz, D, Muñoz-Pérez, R, Velayos, B, Bermejo, F, Busquets, D, Cabacino, M, Camo-Monterde, P, Marín-Jiménez, I, Muñoz, C, de la Peña-Negro, LC, Sierra-Moros, E, Barrio, J, Brunet-Mas, E, Bujanda, L, Cañete, F, Gomollón, F, Manceñido-Marcos, N, Rodríguez-Lago, I, Rodríguez-Grau, MC, Sicilia, B, Torra-Alsina, S, Arranz-Hernández, L, Carpio, D, García-Sepulcre, MF, González-Muñoza, C, Huguet, JM, Márquez-Mosquera, L, López-Serrano, MP, Ponferrada-Díaz, A, Chaparro, M, Gisbert, JP. Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU. DIGESTIVE AND LIVER DISEASE. 2024; 56(11)DOI:10.1016/j.dld.2024.05.009. PMID:38839456. IF:3.800(Q2/3D).

01/10/2024 Examining the therapeutic landscape of beta-blockers in portal hypertension

Brujats, A, Villanueva, C. Examining the therapeutic landscape of beta-blockers in portal hypertension. Clinical and Molecular Hepatology. 2024; 30(4)DOI:10.3350/cmh.2024.0144. PMID:38447532. IF:16.900(Q1/1D).

01/10/2024 Persistent varices in cured patients: Understanding the role of hepatic venous pressure gradient

Olivas, P, Soler-Perromat, A, Tellez, L, Carrion, JA, Alvarado-Tapias, E, Ferrusquia-Acosta, J, Lens, S, Guerrero, A, Falga, A, Vizcarra, P, Orts, L, Perez-Campuzano, V, Shalaby, S, Torres, S, Baiges, A, Turon, F, Garcia-Pagan, JC, Garcia-Criado, A, Hernandez-Gea, V. Persistent varices in cured patients: Understanding the role of hepatic venous pressure gradient. Jhep Reports. 2024; 6(10)DOI:10.1016/j.jhepr.2024.101170. PMID:39430576. IF:7.500(Q1/2D).

01/10/2024 THE GLOBAL PROFILE OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): CLINICAL PRESENTATION, HISTOLOGIC STAGE, NON-INVASIVE TESTS AND MORTALITY FROM THE GLOBAL NAFLD/MASLD REGISTRY

Younossi, Z, Alkhouri, N, Hagström, H, Kim, SU, Crespo, J, Castera, L, Zheng, MH, Treeprasertsuk, S, Shalimer, D, Alswat, K, Fan, JG, Roberts, S, Tsochatzis, E, Dunn, W, Wong, V, Yilmaz, Y, Francque, S, de Oliveira, C, Pessoa, MG, Ekstedt, M, Goh, GBB, Duseja, A, Chan, WK, Fernandez, MIC, Sebastiani, G, Lampertico, P, Alnaamani, K, Valsan, AK, Holleboom, AG, El-Kassas, M, Choudhary, NS, Vessby, J, Singal, A, Kakizaki, S, Pearlman, B, Gunn, N, Cordie, A, Mauricio, D, Kawaguchi, T, Nadeem, R, Shang, Y, Lee, HW, Iruzubieta, P, Liu, WY, Ananchuensook, P, Yang, RX, Zoncapé, M, Dunn, N, Song, SJ, Gadi, Z, Teh, KKJ, Mahadeva, S, Fabian, LG, Cinque, F, D'Ambrosio, R, Friend, E, Poca, M, Colombu, M, Allen, A, Lazarus, J, Lam, B, de Avila, L, Racila, A, Alqahtani, S, Stepanova, M. THE GLOBAL PROFILE OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): CLINICAL PRESENTATION, HISTOLOGIC STAGE, NON-INVASIVE TESTS AND MORTALITY FROM THE GLOBAL NAFLD/MASLD REGISTRY. HEPATOLOGY. 2024; 80DOI:. PMID:. IF:15.800(Q1/1D).

01/09/2024 An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial

Ortiz, O, Daca-Alvarez, M, Rivero-Sanchez, L, Gimeno-Garcia, AZ, Carrillo-Palau, M, Alvarez, V, Ledo-Rodriguez, A, Ricciardiello, L, Pierantoni, C, Hüneburg, R, Nattermann, J, Bisschops, R, Tejpar, S, Huerta, A, Pons, FR, Alvarez-Urturi, C, López-Vicente, J, Repici, A, Hassan, C, Cid, L, Cavestro, GM, Romero-Mascarell, C, Gordillo, J, Puig, I, Herraiz, M, Betes, M, Herrero, J, Jover, R, Balaguer, F, Pellisé, M. An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial. Lancet Gastroenterology & Hepatology. 2024; 9(9)DOI:10.1016/S2468-1253(24)00187-0. PMID:39033774. IF:38.600(Q1/1D).

01/08/2024 Immune Response and Risk of Decompensation following SARS-CoV-2 Infection in Outpatients with Advanced Chronic Liver Disease

Brujats, A, Huerta, A, Osuna-Gómez, R, Guinart-Cuadra, A, Ferrero-Gregori, A, Pujol, C, Soriano, G, Poca, M, Fajardo, J, Escorsell, A, Gallego, A, Vidal, S, Villanueva, C, Alvarado-Tapias, E. Immune Response and Risk of Decompensation following SARS-CoV-2 Infection in Outpatients with Advanced Chronic Liver Disease. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(15)DOI:10.3390/ijms25158302. PMID:39125872. IF:4.900(Q1/3D).

01/07/2024 Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

Ruiz-Cobo, JC, Llaneras, J, Forns, X, Moya, AG, Amiel, IC, Arencibia, A, Diago, M, Garcia-Samaniego, J, Castellote, J, Llerena, S, Rodriguez-Seguel, E, Mateos, B, Rodriguez, M, Zabal, JMR, Fernandez, I, Calleja, JL, Morillas, RM, Montoliu, S, Andrade, RJ, Aranda, EB, Hernandez-Guerra, M, Mate, CJ, Gonzalez-Santiago, JM, de Cuenca, B, Bernal-Monterde, V, Delgado, M, Turnes, J, Lens, S, Buti, M. Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2024; 60(2)DOI:10.1111/apt.18020. PMID:38695095. IF:6.700(Q1/1D).

28/06/2024 Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry

Ferreiro-Iglesias, R, Silva, SP, Marín, S, Casanova, MJ, Mañosa, M, González-Muñoza, C, de Francisco, R, Caballol, B, Arias, L, Piqueras, M, Zabana, Y, Rivero, M, Calvet, X, Mesonero, F, Trastoy, PV, Nistal, RB, Perosanz, RG, Vega, P, Gonzalez-Vivo, M, Iborra, M, Bermejo, F, Madero, L, Rodríguez-Lago, I, Gonzalez, MR, Vera, I, Díaz, AP, Vela, M, Medina, LT, Van Domselaar, M, Gomollón, F, Iglesias, E, Gisbert, JP, Calafat, M, Giordano, A, Pérez-Martínez, I, Ricart, E, Sicilia, B, Mena, R, Esteve, M, Rivas, C, Brunet-Mas, E, Fernández, C, Turrión, MAD, Jiménez, BV, Calvo, MQ, Expósito, CR, Márquez-Mosquera, L, Nos, P, Granja, A, Gutiérrez, A, Cabriada, JL, Cruz, DH, Calvo, M, Pérez, JP, Díaz, YR, Casal, DB, Menacho, M, Leal, C, Lucendo, AJ, Royo, V, Olivares, S, Herrero, BA, Carrillo-Palau, M, Alvarez, PG, Marcos, NM, Martínez-Pérez, TD, Villafranca, MCM, Almela, P, Argüelles-Arias, F, Legido, J, Coronel, AMF, Nieto, L, Domènech, E, Acosta, MBD. Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2024; 60(5)DOI:10.1111/apt.18133. PMID:38943230. IF:6.700(Q1/1D).

24/06/2024 Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA project

González-Muñoza, C, Calafat, M, Gisbert, JP, Iglesias, E, Minguez, M, Sicilia, B, Aceituno, M, Gomollón, F, Calvet, X, Ricart, E, De Castro, L, Rivero, M, Mesonero, F, Márquez, L, Nos, P, Rodriguez-Pescador, A, Guardiola, J, García-Sepulcre, M, García-López, S, Lorente-Poyatos, RH, Alba, C, Sánchez-Ocaña, R, Vera, I, Madero, L, Riestra, S, Navarro-Llavat, M, Pérez-Calle, JL, Camps, B, Van Domselaar, M, Lucendo, AJ, Martin-Arranz, MD, Montoro-Huguet, MA, Sierra-Ausin, M, Llao, J, Carpio, D, Varela, P, Merino, O, Fernandez-Salazar, L, Piqueras, M, Sese, E, Busquets, D, Tardillo, C, Maroto, N, Riera, J, Martinez-Flores, C, Munoz, F, Gordillo-abalos, J, Bertoletti, F, Garcia-Planella, E, Domènech, E. Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA project. POSTGRADUATE MEDICAL JOURNAL. 2024; DOI:10.1093/postmj/qgae076. PMID:38913019. IF:2.700(Q1/3D).

01/06/2024 Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry

Guerra, I, Barros, F, Chaparro, M, Benítez, JM, Martín-Arranz, MD, de Francisco, R, Piqueras, M, de Castro, L, Carbajo, AY, Bermejo, F, Mínguez, M, Gutiérrez, A, Mesonero, F, Cañete, F, González-Muñoza, C, Calvo, M, Sicilia, B, Alfambra, E, Rivero, M, Lucendo, AJ, Tardillo, CA, Almela, P, Bujanda, L, van Domselaar, M, Ramos, L, Sánchez, MF, Hinojosa, E, Verdejo, C, Gimenez, A, Rodriguez-Lago, I, Manceñido, N, Calle, JLP, Moreno, MD, Delgado-Guillena, PG, Antolin, B, de la Piscina, PR, Casanova, MJ, Escribano, PS, Arranz, EM, Perez-Martínez, I, Mena, R, Morales, NG, Granja, A, Watts, MMB, Francés, R, Fernandez, C, Calafat, M, Roig-Ramos, C, Vera, MI, Carracedo, A, Domènech, E, Gisbert, JP. Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry. DIGESTIVE DISEASES. 2024; 42(3)DOI:10.1159/000537782. PMID:38452742. IF:2.100(Q3/7D).

01/06/2024 The Usefulness of Intraepithelial Lymphocyte Immunophenotype Testing for the Diagnosis of Coeliac Disease in Clinical Practice

Gutiérrez-Rios, L, Calafat, M, Pascual, I, Roig, C, Teniente-Serra, A, Vergés, L, González-Muñoza, C, Vayreda, E, Vázquez, D, Gordillo, J, Mañosa, M, Ramírez, C, Garcia-Planella, E, Planella, M, Domènech, E. The Usefulness of Intraepithelial Lymphocyte Immunophenotype Testing for the Diagnosis of Coeliac Disease in Clinical Practice. Nutrients. 2024; 16(11)DOI:10.3390/nu16111633. PMID:38892566. IF:5.000(Q1/2D).

01/06/2024 Comparison in epidemiologyand outcomes of bacterial infections in patients with cirrhosis between university hospitals with and without liver transplant

Torras, C, Bañares, J, Martí, A, Acin, V, Pagès, L, Gutiérrez, L, Casabella, A, Ferrusquía, JA, Sánchez, J, Pérez, M, Fuertes, D, Garcia, M, Soriano, G, Masnou, H, Amador, A, Cuyas, B, Pericàs, JM, Gasch, O, Solé, C. Comparison in epidemiologyand outcomes of bacterial infections in patients with cirrhosis between university hospitals with and without liver transplant. JOURNAL OF HEPATOLOGY. 2024; 80DOI:. PMID:. IF:33.000(Q1/1D).

01/06/2024 Safety and tolerability of long-term albumin treatment in patients with decompensated cirrhosis

Fernández, J, Núñez, L, Costa, M, Torres, M, Horrillo, R, Afonso, N, Mestre, A, Del Arbol, LR, Villanueva, C, Paez, A, Arroyo, V. Safety and tolerability of long-term albumin treatment in patients with decompensated cirrhosis. JOURNAL OF HEPATOLOGY. 2024; 80DOI:. PMID:. IF:33.000(Q1/1D).

01/06/2024 Evaluation of portal hemodynamics after etiological factor removal and persistence of varices in patients with an HVPG <10 mmHg and NITs within the grey zone

Alberch, PO, Soler, A, Téllez, L, Carrión, JA, Alvarado-Tapias, E, Ferrusquía, JA, Lens, S, Guerrero, A, Falgà, MA, Vizcarra, P, Orts, L, Perez, V, Shalaby, S, Baiges, A, Turon, F, García-Pagán, JC, García-Criado, MA, Hernández-Gea, V. Evaluation of portal hemodynamics after etiological factor removal and persistence of varices in patients with an HVPG <10 mmHg and NITs within the grey zone. JOURNAL OF HEPATOLOGY. 2024; 80DOI:. PMID:. IF:33.000(Q1/1D).

01/05/2024 Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)

Garcia, MJ, Riestra, S, Amiot, A, Julsgaard, M, de la Filia, IG, Calafat, M, Aguas, M, de la Pena, L, Roig, C, Caballol, B, Casanova, MJ, Farkas, K, Boysen, T, Bujanda, L, Cuaran, C, Dobru, D, Fousekis, F, Gargallo-Puyuelo, CJ, Savarino, E, Calvet, X, Huguet, JM, Kupcinskas, L, López-Cardona, J, Raine, T, van Oostrom, J, Gisbert, JP, Chaparro, M. Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study). ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2024; 59(10)DOI:10.1111/apt.17938. PMID:38445785. IF:6.700(Q1/1D).

01/05/2024 Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA

Gómez-Labrador, C, Ricart, E, Iborra, M, Iglesias, E, Martín-Arranz, MD, de Castro, L, De Francisco, R, García-Alonso, FJ, Sanahuja, A, Gargallo-Puyuelo, CJ, Mesonero, F, Casanova, MJ, Mañosa, M, Rivero, M, Calvo, M, Sierra-Ausin, M, González-Muñoza, C, Calvet, X, García-López, S, Guardiola, J, García, LA, Márquez-Mosquera, L, Gutiérrez, A, Zabana, Y, Navarro-Llavat, M, Poyatos, RL, Piqueras, M, Torrealba, L, Bermejo, F, Ponferrada-Díaz, A, Pérez-Calle, JL, Barreiro-de Acosta, M, Tejido, C, Cabriada, JL, Marín-Jiménez, I, Roncero, O, Ber, Y, Fernández-Salazar, L, Aler, BC, Lucendo, AJ, Llaó, J, Bujanda, L, Villafranca, CM, Domènech, E, Chaparro, M, Gisbert, JP. Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA. Pharmaceutics. 2024; 16(5)DOI:10.3390/pharmaceutics16050629. PMID:38794292. IF:5.500(Q1/1D).

22/04/2024 Long-term risk of delayed postoperative Crohn's disease recurrence in patients with no or mild endoscopic recurrence at first assessment

Manosa, M, Riviere, P, de Greef, I, Oller, B, Roig, C, Calafat, M, Garcia-Planella, E, Laharie, D, Ferrante, M, Domenech, E. Long-term risk of delayed postoperative Crohn's disease recurrence in patients with no or mild endoscopic recurrence at first assessment. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54(8)DOI:10.1111/eci.14219. PMID:38647188. IF:3.600(Q1/2D).

18/04/2024 Influence of further decompensation on survival across clinical stages of decompensated cirrhosis: The role of portal hypertension and HVPG changes

Garcia-Guix, M, Ardevol, A, Sapena, V, Alvarado-Tápias, E, Huertas, A, Brujats, A, Fajardo, J, Cuyas, B, Poca, M, Guarner, C, Torras, X, Escorsell, A, Villanueva, C. Influence of further decompensation on survival across clinical stages of decompensated cirrhosis: The role of portal hypertension and HVPG changes. LIVER INTERNATIONAL. 2024; 44(8)DOI:10.1111/liv.15937. PMID:38634685. IF:5.200(Q1/2D).

12/04/2024 An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study

Dunn, W, Li, YM, Singal, AK, Simonetto, DA, Diaz, LA, Idalsoaga, F, Ayares, G, Arnold, J, Ayala-Valverde, M, Perez, D, Gomez, J, Escarate, R, Fuentes-Lopez, E, Ramirez-Cadiz, C, Morales-Arraez, D, Zhang, W, Qian, SV, Ahn, JC, Buryska, S, Mehta, H, Dunn, N, Waleed, M, Stefanescu, H, Bumbu, A, Horhat, A, Attar, B, Agrawal, R, Cabezas, J, Echavaria, V, Cuyas, B, Poca, M, Soriano, G, Sarin, SK, Maiwall, R, Jalal, PK, Higuera-de-la-Tijera, F, Kulkarni, AV, Rao, PN, Guerra-Salazar, P, Skladany, L, Kubanek, N, Prado, V, Clemente-Sanchez, A, Rincon, D, Haider, T, Chacko, KR, Romero, GA, Pollarsky, FD, Restrepo, JC, Toro, LG, Yaquich, P, Mendizabal, M, Garrido, ML, Marciano, S, Dirchwolf, M, Vargas, V, Jimenez, C, Hudson, D, Garcia-Tsao, G, Ortiz, G, Abraldes, JG, Kamath, PS, Arrese, M, Shah, VH, Bataller, R, Arab, JP. An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study. HEPATOLOGY. 2024; 80(5)DOI:10.1097/HEP.0000000000000883. PMID:38607809. IF:15.800(Q1/1D).

01/04/2024 Further decompensation in cirrhosis. Results of a large multicenter cohort study supporting Baveno VII statements

D'Amico, G, Zipprich, A, Villanueva, C, Sordà, JA, Morillas, RM, Garcovich, M, Retortillo, MG, Martinez, J, Cales, P, D'Amico, M, Dollinger, M, García-Guix, M, Ballerga, EG, Tsochatzis, E, Cirera, I, Albillos, A, Roquin, G, Pasta, L, Colomo, A, Daruich, J, Canete, N, Boursier, J, Dallio, M, Gasbarrini, A, Iacobellis, A, Gobbo, G, Merli, M, Federico, A, Baroni, GS, Pozzoni, P, Addario, L, Chessa, L, Ridola, L, Garcia-Tsao, G. Further decompensation in cirrhosis. Results of a large multicenter cohort study supporting Baveno VII statements. HEPATOLOGY. 2024; 79(4)DOI:10.1097/HEP.0000000000000652. PMID:37916970. IF:15.800(Q1/1D).

01/04/2024 Plastic pigtail vs lumen-apposing metal stents for drainage of walled-off necrosis (PROMETHEUS study): an open-label, multicenter randomized trial

Gornals, JB, Velasquez-Rodriguez, JG, Bas-Cutrina, F, De Paredes, AGG, Esteban, JM, Teran, A, Gonzalez-Huix, F, Perez-Miranda, M, Guarner-Argente, C, Vila, JJ, Garcia-Sumalla, A, Foruny, JR, Fisac-Vazquez, J, Moris, M, Miquel-Salas, I, Higuera, CD, Murzi-Pulgar, M, Sanchez-Yague, A, Salord, S, Ruiz-Osuna, S, Busquets, J, Sanllorente-Melenchon, M, Videla, S, Moreno, R, Tebe-Cordomi, C, Hereu, P, Vazquez-Sequeiros, E. Plastic pigtail vs lumen-apposing metal stents for drainage of walled-off necrosis (PROMETHEUS study): an open-label, multicenter randomized trial. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES. 2024; 38(4)DOI:10.1007/s00464-024-10699-w. PMID:38448625. IF:2.700(Q1/3D).

22/03/2024 The Natural History of Patients With Pre-Existing and De Novo Inflammatory Bowel Disease After Solid Organ Transplantation: EITOS Study of GETECCU

Bastón-Rey, I, Rodríguez-Lago, I, Luque, AM, Caballol, B, Soutullo-Castiñeiras, C, Bravo, A, Castaño, A, Gros, B, Bernal, L, Diz-Lois, MT, Alonso-Galan, H, Canete, F, Castro, B, Perez-Galindo, P, Gonzalez-Munoza, C, El Hajra, I, Martínez-Montiel, P, Alonso-Abreu, I, Mesonero, F, González-Vivo, M, Peries, L, Martín-Arranz, E, Abril, C, Marin-Jiménez, I, Baltar, R, Vicuña, M, Moreno, N, Brunet, E, de Célix, CR, Fajardo, I, Cruz, N, Calvino-Suárez, C, Rojas-Feria, M, Fernández-Clotet, A, Gimeno-Torres, M, Nieto-Garcia, L, de la Iglesia, D, Zabana, Y, Suarez-Ferrer, C, de Acosta, MB. The Natural History of Patients With Pre-Existing and De Novo Inflammatory Bowel Disease After Solid Organ Transplantation: EITOS Study of GETECCU. INFLAMMATORY BOWEL DISEASES. 2024; 31(1)DOI:10.1093/ibd/izae041. PMID:38518109. IF:4.300(Q1/3D).

01/03/2024 A comprehensive examination of small-bowel capsule endoscopy in Spanish centers to meet European Society of Gastrointestinal Endoscopy standards

Villagrá, MG, de Frías, CP, de la Mata, DMA, Alonso-Sierra, M, Alonso-Lazaro, N, Caballero, N, Ceballos, FS, Compañy, L, Valenzuela, JE, Esteban, P, Farráis, S, Fernández-Urién, I, Galvez, C, García, A, Lledó, JG, Suárez, BG, Jiménez-García, VA, Lujan-Sanchís, M, Muñoz, BM, Romero-Mascarell, C, Acosta, MS, Cortázar, EV, Giordano, A, Carretero, C. A comprehensive examination of small-bowel capsule endoscopy in Spanish centers to meet European Society of Gastrointestinal Endoscopy standards. Endoscopy International Open. 2024; 12(03)DOI:10.1055/a-2252-8946. PMID:38481597. IF:(Q/D).

12/02/2024 A framework for the evaluation of Human Machine Interfaces of robot-assisted colonoscopy

Finocchiaro M., Banfi T., Donaire S., Arezzo A., Guarner-Argente C., Menciassi A., Casals A., Ciuti G., Hernansanz A.. A framework for the evaluation of Human Machine Interfaces of robot-assisted colonoscopy. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING. 2024; 71(2)DOI:10.1109/TBME.2023.3301741. PMID:37535479. IF:4.500(Q2/4D).

12/02/2024 Implementation of esophageal endoscopic submucosal dissection in Spain: Results from the nationwide registry

Rodríguez de Santiago E., Herreros-de-Tejada A., Albéniz E., Ramos Zabala F., Fernández-Esparrach G., Nogales O., Rosón P., Peñas García B., Uchima H., Terán Á., Rodríguez Sánchez J., de Frutos D., Parejo Carbonell S., Santiago J., Díaz Tasende J., Guarner Argente C., de María Pallarés P., Amorós A., Barranco D., Álvarez de Castro D., Muñoz González R., Marín-Gabriel J.C.. Implementation of esophageal endoscopic submucosal dissection in Spain: Results from the nationwide registry. Gastroenterologia y Hepatologia. 2024; 47(2)DOI:10.1016/j.gastrohep.2023.02.008. PMID:36870477. IF:1.900(Q3/7D).

01/02/2024 Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant data

Villanueva, C, Sapena, V, Lo, GH, Seo, YS, Shah, HA, Singh, V, Tripathi, D, Schepke, M, Gheorghe, C, Bonilha, DQ, Jutabha, R, Wang, HM, Rodrigues, SG, Brujats, A, Lee, HA, Azam, Z, Kumar, P, Hayes, PC, Sauerbruch, T, Chen, WC, Iacob, S, Libera, ED, Jensen, DM, Alvarado, E, Torres, F, Bosch, J. Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant data. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2024; 59(3)DOI:10.1111/apt.17824. PMID:38108646. IF:6.700(Q1/1D).

01/01/2024 Risks, indications and technical aspects of colonoscopy in elderly or frail patients. Position paper of the Societat Catalana de Digestologia, the Societat Catalana de Geriatria i Gerontologia and the Societat Catalana de Medicina de Familia i Comunitaria

Machlab S., Francia E., Mascort J., García-Iglesias P., Mendive J.M., Riba F., Guarner-Argente C., Solanes M., Ortiz J., Calvet X.. Risks, indications and technical aspects of colonoscopy in elderly or frail patients. Position paper of the Societat Catalana de Digestologia, the Societat Catalana de Geriatria i Gerontologia and the Societat Catalana de Medicina de Familia i Comunitaria. Gastroenterologia y Hepatologia. 2024; 47(1)DOI:10.1016/j.gastrohep.2023.05.004. PMID:37209916. IF:1.900(Q3/7D).

01/01/2024 Impact of the COVID-19 pandemic on the incidence and type of infections in hospitalized patients with cirrhosis: a retrospective study

Cuyàs B., Huerta A., Poca M., Alvarado-Tapias E., Brujats A., Román E., Guarner C., Escorsell À., Soriano G.. Impact of the COVID-19 pandemic on the incidence and type of infections in hospitalized patients with cirrhosis: a retrospective study. Scientific Reports. 2024; 14(1)DOI:10.1038/s41598-024-52452-2. PMID:38302563. IF:3.900(Q1/2D).

01/01/2024 Clinical application of ICCE criteria for suspected Crohn's disease undergoing small bowel capsule endoscopy

Ramos, CR, Giordano, A, Porti, JA, Avalos, JG, Bertoletti, F, Muñoza, CG, Planella, EG, Argente, CG, Mascarell, CR. Clinical application of ICCE criteria for suspected Crohn's disease undergoing small bowel capsule endoscopy. Journal of Crohns & Colitis. 2024; 18DOI:. PMID:. IF:8.700(Q1/1D).

01/01/2024 Predicting survival in patients with 'non-high-risk' acute variceal bleeding receiving b-blockers plus ligation to prevent re-bleeding

Balcar, L, Mandorfer, M, Hernandez-Gea, V, Procopet, B, Meyer, EL, Giráldez, A, Amitrano, L, Villanueva, C, Thabut, D, Samaniego, LI, Silva, G Jr, Martinez, J, Genescà, J, Bureau, C, Trebicka, J, Herrera, EL, Laleman, W, Azorín, JMP, Alonso, JC, Gluud, LL, Ferreira, CN, Cañete, N, Rodríguez, M, Ferlitsch, A, Mundi, JL, Gronbæk, H, Guerra, MNH, Sassatelli, R, Dell'Era, A, Senzolo, M, Abraldes, JG, Romero-Gómez, M, Zipprich, A, Casas, M, Masnou, H, Primignani, M, Krag, A, Nevens, F, Calleja, JL, Jansen, C, Catalina, MV, Albillos, A, Rudler, M, Tapias, EA, Guardascione, MA, Tantau, M, Schwarzer, R, Reiberger, T, Laursen, SB, Lopez-Gomez, M, Cachero, A, Ferrarese, A, Ripoll, C, La Mura, V, Bosch, J, Garcia-Pagán, JC. Predicting survival in patients with 'non-high-risk' acute variceal bleeding receiving b-blockers plus ligation to prevent re-bleeding. JOURNAL OF HEPATOLOGY. 2024; 80(1)DOI:10.1016/j.jhep.2023.10.007. PMID:37852414. IF:33.000(Q1/1D).

01/01/2024 Impact of Crohn's Disease Location on Biologic Therapy Persistence and the Risk of Intestinal Surgery: Insights from the ENEIDA Registry (the DISCOLOC Study)

Giordano, A, Martínez, IP, Gisbert, JP, Ricart, E, Dolores, MAM, Mesonero, F, Luisa, DCPM, Rivero, M, Flores, EI, Fernández-Prada, S, Calafat, M, Villarino, MA, Turrión, MAD, Rodriguez-Gonzalez, E, Roche, PC, Carpio, D, Brunet, E, Moranta, FR, García, LA, Pascual, I, Bermejo, F, Madero, L, Esteve, M, Muñoza, CG, Martínez-Montiel, P, Huguet, JM, Calle, JLP, Rodríguez-Lago, I, Ausín, MS, Poyatos, RHL, García-Bosch, O, Marín, GS, Taxonera, C, Ponferrada-Díaz, A, Barreiro-de Acosta, M, Bujanda, L, Serra, RB, Ramos, L, Domènech, E, Planella, EG. Impact of Crohn's Disease Location on Biologic Therapy Persistence and the Risk of Intestinal Surgery: Insights from the ENEIDA Registry (the DISCOLOC Study). Journal of Crohns & Colitis. 2024; 18DOI:. PMID:. IF:8.700(Q1/1D).

01/01/2024 The ileorectal anastomosis after a total colectomy is a feasible and valid surgical alternative in the treatment of inflammatory bowel disease

Tapiolas, I, Mañosa, M, Troya, J, Vela, S, Pares, D, Mesonero, F, Valera, P, Riestra, S, Iglesias, E, Rodríguez-González, E, Guardiola, J, López, SG, Carpio, D, Vega, P, Arranz, MDM, Ramos, L, Busquets, D, Sierra, M, Montiel, PM, Sicilia, B, Ricart, E, Planella, EG, Huguet, JM, Vera, I, Gomollon, F, Rivero, M, De Castro, L, de Acosta, MB, Lago, IR, Gisbert, JP, Sepulcre, MFG, Calvet, X, Bermejo, F, Calle, JLP, Gutierrez, A, Lucendo, AJ, Vilafranca, MDCM, Llavat, MN, Calafat, M, Domenech, E. The ileorectal anastomosis after a total colectomy is a feasible and valid surgical alternative in the treatment of inflammatory bowel disease. Journal of Crohns & Colitis. 2024; 18DOI:. PMID:. IF:8.700(Q1/1D).